The specifics of allergen recognition by CD4+ T lymphocytes at the epitope level

Clinical and Experimental Allergy

Volumn 44, Issue 7, 2014, Pages 898-900

  Moingeon, P ^a  

^a Stallergenes SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLLEN EXTRACT;

ALGORITHM; AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SPECIFICITY; CROSS REACTION; EDITORIAL; GRASS POLLEN; HUMAN; MOLECULAR RECOGNITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHLEUM PRATENSE; PRIORITY JOURNAL; DESENSITIZATION; IMMUNOLOGY; POACEAE; T LYMPHOCYTE SUBPOPULATION;

ALLERGENS; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; POACEAE; T-LYMPHOCYTE SUBSETS;

EID: 84904602096     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12343     Document Type: Editorial

References (16)

1. McMichael AJ, Kelleher A. The arrival of HLA class II tetramers. J Clin Invest 1999; 104:1669-70.
2. Wambre E, Van Overtvelt L, Maille're B et al. Single cell assessment of allergen-specific T cell responses with MHC-class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol 2008; 146:99-112.
3. Macaubas C, Wahlstrom J, Galvao da Silva AP et al. Allergen-specific MHC-class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 2006; 176:5069-77.
4. + T cells. J Allergy Clin Immunol 2006; 118:1350-6.
5. Kinnunen T, Jutila K, Kwok WW et al. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy. J Allergy Clin Immunol 2007; 119:965-72.
6. Van Overtvelt L, Wambre E, Maillière B et al. Assesment of Bet v 1-specific CD4+ T cell responses in allergic and non allergic individuals using MHC class II peptide tetramers. J Immunol 2008; 180:4515-22.
7. John-Schmidt B, Sirven P, Leb V et al. Characterization of HLA class II/peptide TCR interactions of the immunodominant T cell epitope in Art v 1, the major Artemisia pollen allergen. J Immunol 2008; 181:3636-42.
8. Wambre E, Bonvalet M, Bodo V et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4+ T cell responses. Clin Exp Allergy 2011; 41:192-203.
9. Delong J, Hetherington K, Wambre E et al. Ara h1 reactive T cells in peanut allergic individuals. J Allergy Clin Immunol 2011; 127:1211-8.
10. Archila LD, DeLong JH, Wambre E, James EA, Robinson DM, Kwok WW. Grass-specific CD4+ T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy. Clin Exp Allergy 2014; 44:986-98.
11. Hrabina M, Peltre G, Van Ree R, Moingeon P. Grass pollen allergens. Clin Exp Allergym 2008; 8:7-11.
12. Schenk S, Breiteneder H, Susani M et al. T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J Allergy Clin Immunol 1995; 96:986-96.
13. Muller WD, Karamfilov T, Kahlert H et al. Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens. Clin Exp Allergy 1998; 28:1538-48.
14. Chabre H, Gouyon B, Adam A et al. Molecular variability of group 1 and 5 gras pollen allergens between Pooideae species: implications for specific immunotherapy. Clin Exp Allergy 2010; 40:505-19.
15. Wambre E, Delong JH, James EA et al. Specific immunotherapy modifies allergen-specific CD4+ T cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2013; 133:872-9.
16. Gabrysova L, Wraith DC. Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol 2010; 40:1386-95.